Save
Siponimod effect on cortical and deep grey matter in patients with secondary progressive multiple sclerosis
ECTRIMS Online Library, Douglas L Arnold, 228117
Microglial-dependent neurodegeneration in multiple sclerosis is fueled by pHERV-W envelope protein
ECTRIMS Online Library, David Kremer, 228132
How does anti-IL-6 receptor monoclonal antibody tocilizumab treatment ameliorate neuromyelitis optica?
ECTRIMS Online Library, Takako Matsuoka, 228133
Extended interval dosing of natalizumab shows comparable efficacy to standard interval dosing starting from the second year of treatment
ECTRIMS Online Library, Serena Ruggieri, 228148
Pregnancy outcomes from the global pharmacovigilance database on interferon beta-1b exposure
ECTRIMS Online Library, Alessandra Adamo, 228149
The absorption and activity of a novel form of biotin, JDS-MB-001, in a hippocampal demyelination animal model
ECTRIMS Online Library, James Komorowski, 228164
Investigating brain plasticity underlying the early stages of functional recovery in MS
ECTRIMS Online Library, Eleonora Patitucci, 228165
Early clinical predictors of severe MS
ECTRIMS Online Library, Charles Benjamin Malpas, 228824
MOG-IgG antibodies in autoimmune demyelinating CNS disorders - retrospective analysis of a monocentric patient cohort
ECTRIMS Online Library, Krenar Veselaj, 228825
US-based African Americans with multiple sclerosis have greater disability and lower socio-economic status than Caucasian Americans
ECTRIMS Online Library, Karla Gray-Roncal, 228840
Association between demographic factors, DMT utilization and DMT switching on MS relapse rates
ECTRIMS Online Library, James Marriott, 228841
Subclinical cochlear involvement in newly diagnosed relapsing-remitting multiple sclerosis
ECTRIMS Online Library, Maria Albanese, 228857
Heterogeneity of EDSS progression assessment in patients with MS in different geographical regions
ECTRIMS Online Library, Francesca Bovis, 228859
Effect of MD1003 (high dose pharmaceutical grade biotin) on remotely monitored ambulatory activity in progressive MS: initial step count data of the phase 3 SPI2 study
ECTRIMS Online Library, Bruce Cree, 228874
Re-evaluating an algorithm to identify multiple sclerosis relapse in insurance claims databases
ECTRIMS Online Library, Erru Yang, 228875
Impact of comorbidity and DMT use on disability status by DMT group in participants in the Pacific Northwest MS Registry
ECTRIMS Online Library, Elizabeth Baraban, 228890
Sleep in Portuguese patients with multiple sclerosis: questionnaire-based study
ECTRIMS Online Library, Ariana Barros, 228891
The new in vitro blood-brain barrier (BBB) model under shear forces with multi-culture of BBB components in multiple sclerosis
ECTRIMS Online Library, Yukio Takeshita, 228906
Imaging and biodistribution of a novel anti-CD20 antibody following subcutaneous administration in control and experimental autoimmune encephalomyelitis-variant mice
ECTRIMS Online Library, Mary-Anne Migotto, 228907
Single cell transcriptomics identifies an MS-specific composition and expression of cerebrospinal fluid cells
ECTRIMS Online Library, Gerd Meyer zu Hörste, 228922
Herpesviruses seroprevalence and B-cell immunophenotype in multiple sclerosis
ECTRIMS Online Library, Ana Zabalza, 228923
Longitudinal characterization of optic nerve and retinal pathology in experimental autoimmune encephalomyelitis
ECTRIMS Online Library, Praveena Manogaran, 228938
Individual grey matter network properties forecast disease progression in multiple sclerosis
ECTRIMS Online Library, Gabriel Gonzalez Escamilla, 228939
Thalamic volume predicts disability progression in multiple sclerosis: a 6-year prospective study
ECTRIMS Online Library, Elias Sotirchos, 228954
Monitoring myelin changes using advanced magnetic resonance imaging in multiple sclerosis patients treated with ocrelizumab over 48 months
ECTRIMS Online Library, Irene Vavasour, 228955
TAPAS: threshold adjustment to probability map automatic segmentations
ECTRIMS Online Library, Alessandra M. Valcarcel, 228970
Ultra-high MR field quantification of infratentorial atrophy in multiple sclerosis
ECTRIMS Online Library, Matilde Inglese, 228971
Using normalized thalamic brain volume and lesion load to identify distinct phenotypes in early relapsing multiple sclerosis patients
ECTRIMS Online Library, Roland Opfer, 228986
Altered brain network modules in MS identified using magnetoencephalography: a less connected state
ECTRIMS Online Library, Eva M.M. Strijbis, 228987
Association of cognitive impairment with spinal cord MRI measures in radiologically isolated syndrome
ECTRIMS Online Library, Jiwon Oh, 229002
Rates of longitudinal cognitive decline in multiple sclerosis: characterization with a large sample and baseline clinical predictors
ECTRIMS Online Library, Tom Fuchs, 229003
Spinal cord lesions correlate with blood sNfL levels in multiple sclerosis
ECTRIMS Online Library, Falk Steffen, 229018
The vasopressin surrogate copeptin correlates with ACTH and cortisol concentrations in the DexCRH-test in healthy controls, but not in MS patients
ECTRIMS Online Library, Muriel Stoppe, 229019
Switching stable RRMS patients from natalizumab to alemtuzumab - efficacy and safety in the real world
ECTRIMS Online Library, Stephan Richter, 229034
Treatment discontinuation in the Big Multiple Sclerosis Data Network: a descriptive analysis
ECTRIMS Online Library, Tim Spelman, 229035
Lymphocyte changes induces by alemtuzumab in multiple sclerosis patients
ECTRIMS Online Library, Silvia Medina, 229050
Low dose rituximab depletes B cells and lowers IgM in blood in MS patients: a study on possible biomarkers to predict treatment response and adverse event profile
ECTRIMS Online Library, Björn Evertsson, 229051
P2X7: a target for neuroprotection and neuroinflammation in multiple sclerosis
ECTRIMS Online Library, Ross Gruber, 229066
An integral measure of serial neurofilament light chain assessments in blood is a predictor of long-term disability progression in relapsing-remitting multiple sclerosis
ECTRIMS Online Library, Jens Kuhle, 229067
A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of fingolimod (IMSE 2)
ECTRIMS Online Library, Anna Fält, 229068
Safety and effectiveness of less frequent dosing of natalizumab in relapsing remitting multiple sclerosis (RRMS) patients in a dedicated MS center in Greece - an eleven years experience
ECTRIMS Online Library, Clementine Karageorgiou, 229082
False positive B viral hepatitis testing in MS patients receiving high dose of biotin
ECTRIMS Online Library, Valerie Pourcher, 229083
Effect of extended dosing of natalizumab on VLA-4 saturation
ECTRIMS Online Library, Roy Johanson, 229084
Improvements across functional systems are maintained regardless of early vs late confirmed disability improvement: CARE-MS 6-year follow-up
ECTRIMS Online Library, P Vermersch, 229098
Fluorine-19 magnetic resonance imaging as a method for the individualized theranostic of fluorine labelled drugs in neuroinflammation
ECTRIMS Online Library, Christian Prinz, 229099
Dimethyl fumarate-induced lymphocyte drop at six months predicts short-term disease activity in multiple sclerosis: an independent, prospective, post-marketing evaluation
ECTRIMS Online Library, Carla Tortorella, 229100
“Keep going!” Symptoms of depression, sleep disturbances, fatigue and anxiety improved 12 weeks after exercising and active leisure time activity, but decreased further 16 weeks later - evidence for a continuous exercising program
ECTRIMS Online Library, Dena Sadeghi Bahmani, 229114
Glatiramer acetate slows disability progression - final 10-year results from UK Risk Sharing Scheme
ECTRIMS Online Library, Sarah Al-Izki, 229115
Life-threatening vitamin D intoxication due to intake of ultra-high doses in multiple sclerosis: a case report
ECTRIMS Online Library, Julia Feige, 229116
Quantitative neuroimaging in multiple sclerosis (MS): which biomarker is the most reliable in the evaluation of MS-induced atrophy?
ECTRIMS Online Library, Elefterios Makras, 229130
Comparative efficacy of teriflunomide versus dimethyl-fumarate on clinical and MRI outcomes: a two years French multicenter observational study
ECTRIMS Online Library, David Laplaud, 231975
Comparative effectiveness of teriflunomide and dimethyl fumarate in relapsing remitting multiple sclerosis. A Danish nationwide cohort study
ECTRIMS Online Library, Mathias Due Buron, 231976
Comparative effectiveness of dimethylfumarate and fingolimod in an Italian monocentric cohort of relapsing remitting multiple sclerosis patients
ECTRIMS Online Library, Lucia Moiola, 231977
Final results of a placebo controlled, Phase 2 multicenter study of ublituximab (UTX), a novel glycoengineered anti-CD20 monoclonal antibody (mAb), in patients with relapsing forms of multiple sclerosis (RMS)
ECTRIMS Online Library, Edward Fox, 231978
The use of autologous haematopoietic stem cell transplantation as a first line disease modifying therapy in patients with 'aggressive' multiple sclerosis
ECTRIMS Online Library, Joyutpal Das, 231979
Leptomeningeal enhancement in the brain on 7T MRI scans is common and is associated with cortical lesions in relapsing-remitting multiple sclerosis
ECTRIMS Online Library, Jonathan Zurawski, 231980
Quantification of spinal cord atrophy in MS: which software, which vertebral level, spinal cord or brain MRI? A multi-centric, longitudinal comparison of three different volumetric approaches
ECTRIMS Online Library, Carsten Lukas, 231981
Advocacy for surrogacy: magnetisation transfer ratio indicates cortical multiple sclerosis lesion load in vivo
ECTRIMS Online Library, Niraj Mistry, 231982
Detection of multiple sclerosis in brain MRIs using 3D convolutional networks
ECTRIMS Online Library, Kerstin Ritter, 231983
Occurrence of non-linear brain volume loss trajectories in multiple sclerosis patients
ECTRIMS Online Library, Tomas Uher, 231984
Deep immune-profiling of monozygotic twins discordant for multiple sclerosis indicates that genetic identity overrides disease-specific immune features
ECTRIMS Online Library, Lisa Ann Gerdes, 231985
High-dimensional profiling of single memory CD8+T cells reveals a specific pattern in multiple sclerosis patients
ECTRIMS Online Library, Emilie Dugast, 231986
Increased acute axonal injury and elevated oligodendroglial numbers in spinal normal-appearing white matter in MS as compared to neuromyelitis optica
ECTRIMS Online Library, Christiane Wegner, 231987
Substantial 'subependymal-in' gradient of thalamic damage in progressive multiple sclerosis
ECTRIMS Online Library, Roberta Magliozzi, 231988
T-bet-expressing B cells as key drivers of multiple sclerosis: from peripheral induction to local recruitment
ECTRIMS Online Library, Marvin M. van Luijn, 231989
Clinician's view (Europe)
ECTRIMS Online Library, Eva Kubala Havrdová, 231990
Follow-on products for treatment of multiple sclerosis in Latin America: an update
ECTRIMS Online Library, Jorge Correale, 231991
MS society´s view
ECTRIMS Online Library, Michelle Mitchell, 231992
Case 1: The features of anti-MOG antibody-associated CNS demyelination: NMOSD, MS or a novel disease entity?
ECTRIMS Online Library, Martin Weber, 231993
Two cases of anti-MOG associated CNS demyelinating disease
ECTRIMS Online Library, Tobias Derfuss, 231994
When to stop immunotherapy?
ECTRIMS Online Library, John Corboy, 231952
The optimal time to start treatment in relapsing remitting multiple sclerosis patients: results from the Big Multiple Sclerosis Data Network
ECTRIMS Online Library, Pietro Iaffaldano, 231953
Plasma neurofilament light levels segregate treatment effects: results from the IMSE studies with multiple disease modulatory drugs
ECTRIMS Online Library, Bénédicte Delcoigne, 231954
Recurrence of disease activity after fingolimod discontinuation - observations in a real-world cohort with 433 multiple sclerosis patients
ECTRIMS Online Library, Nuria Cerdá Fuertes, 231955
Disease activity during pregnancy after fingolimod withdrawal due to planning a pregnancy in women with multiple sclerosis
ECTRIMS Online Library, Spalmai Hemat, 231956
Update on pathogenesis
ECTRIMS Online Library, Monika Bradl, 231957
Update on therapy
ECTRIMS Online Library, Tania Kümpfel, 231958
The Hungarian population-based prevalence and incidence study of neuromyelitis optica spectrum disorder
ECTRIMS Online Library, Viktoria Papp, 231959
Predictors of outcome after a first attack of Neuromyelitis Optica
ECTRIMS Online Library, Maxime Guillaume, 231960
Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study
ECTRIMS Online Library, Frederike Cosima Oertel, 231961
Serum glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL) in neuromyelitis optica spectrum disorders
ECTRIMS Online Library, Mitsuru Watanabe, 231962
Targeting glia as a strategy to prevent neurodegeneration in MS
ECTRIMS Online Library, Charles ffrench-Constant, 231964
Structural and functional alterations of pyramidal neurons in a model of cortical multiple sclerosis
ECTRIMS Online Library, Adrian-Minh Schumacher, 231965
Nimodipine reduces acute relapse and prevents demyelination in models of multiple sclerosis
ECTRIMS Online Library, Kenneth Smith, 231966
Microglial interaction with nodes of Ranvier: a role in repair?
ECTRIMS Online Library, Thomas Roux, 231967
Selective reduction of AMPA receptors on mature oligodendrocytes prevents demyelination and axonal injury in experimental autoimmune encephalomyelitis
ECTRIMS Online Library, Kirsten Evonuk, 231968
MRI and the diagnosis of MS: from MAGNIMS 2016 to the 2017 revision of the McDonald criteria
ECTRIMS Online Library, Massimo Filippi, 231969
Application of MRI diagnostic criteria in clinical practice
ECTRIMS Online Library, Mar Tintore, 231970
MRI and multiple sclerosis misdiagnosis and differential diagnosis
ECTRIMS Online Library, Frederik Barkhof, 231971
Overview
ECTRIMS Online Library, Vincent de Groot, 231972
Exercise for gait therapy
ECTRIMS Online Library, Peter Feys, 231973
Pharmacological and non-pharmacological treatment of fatigue
ECTRIMS Online Library, Vincent de Groot, 231974
Accuracy versus reproducibility: comprehensive assessment of four automated methods for multiple sclerosis lesion segmentation
ECTRIMS Online Library, Mário João Fartaria, 229576
Evolving MS treatment with immune reconstitution therapy
ECTRIMS Online Library, Gavin Giovannoni, 231941
Committing to patients, impacting individuals: towards an individualised approach for patients with MS
ECTRIMS Online Library, Session Speakers, 234394
Affinity proteomics for array based profiling of autoantibody repertoires
ECTRIMS Online Library, Peter Nilsson, 231932
High-dimensional cytometry for immunophenotyping
ECTRIMS Online Library, Burkhard Becher, 231933
Depression and fatigue: how to break the vicious circle
ECTRIMS Online Library, Anthony Feinstein, 231936
Grand perspective on tackling motor impairment
ECTRIMS Online Library, Alan J. Thompson, 231937
What’s in a name? Paediatric MS or another diagnosis?
ECTRIMS Online Library, Tanuja Chitnis, 231938

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings